Canadian Urologic Oncology Group
1 clinical trials · Sponsor
◉ Watch Canadian Urologic Oncology Group
| Record | Firm | Date |
|---|---|---|
| Metformin in Patients Initiating ADT as Prevention and Intervention of Metabolic Syndrome (NCT03031821) | Canadian Urologic Oncology Group | 2018-07-12 |
Track Canadian Urologic Oncology Group automatically
Every clearance here is in the API, with alerts when new ones post.